Analyst firms · Daiwa · PFE
Daiwa PFE price target and rating history
Pfizer Inc. (PFE) · Health Care
Daiwa rates Pfizer Inc. (PFE) Neutral with a $27 price target, as of its latest action on Feb 12, 2026. It has published 4 rating actions on PFE since February 2023, including 2 upgrades and 2 downgrades. Across 8 firms with a PFE price target in the last 12 months, the median target is $26.50. Daiwa's $27 is 2% above that.
- Current rating
- Neutral
- Price target
- $27
- Median target, all firms
- $26.50
- Actions on PFE
- 4
Daiwa price target on PFE
Every Daiwa rating on PFE
- Feb 12, 2026
- Aug 7, 2024
- May 11, 2023
- Feb 7, 2023
How other firms rate PFE
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| DZ Bank | Hold | Nov 6, 2026 | |
| HSBC | Hold | $28 | Jul 6, 2026 |
| RBC Capital Markets | Sector Perform | $25 | Jun 10, 2026 |
| Argus Research | Buy | $35 | Mar 2, 2026 |
| Barclays | Underweight | $25 | Feb 20, 2026 |
| Daiwa | Neutral | $27 | Feb 12, 2026 |
| UBS | Neutral | $25 | Jan 7, 2026 |
| Citigroup | Neutral | $26 | Dec 2, 2025 |
| Scotiabank | Sector Outperform | $30 | Nov 13, 2025 |
Questions about Daiwa and PFE
- What is Daiwa's price target for PFE?
- Daiwa's latest stated price target for Pfizer Inc. (PFE) is $27, from its action on Feb 12, 2026.
- What is Daiwa's rating on PFE?
- Daiwa rates PFE Neutral, a neutral rating, as of Feb 12, 2026.
- When did Daiwa last change its view on PFE?
- On Feb 12, 2026, Daiwa downgrades to Neutral from Outperform, price target $27.
- How does Daiwa's PFE target compare with other analysts?
- Across 8 firms with a PFE price target in the last 12 months, the median target is $26.50. Daiwa's $27 is 2% above that.
More PFE rating histories
All Daiwa ratingsPFE news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.